Hepatitis B virus DNA polymerase — Drug Target

All drugs that target Hepatitis B virus DNA polymerase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nucleoside reverse transcriptase inhibitor

Phase 3 pipeline (1)

• telbivudine or lamivudine · Novartis · Nucleoside reverse transcriptase inhibitor · Infectious Disease
  Telbivudine and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the replication of viral DNA.